SLDB
SLDB
NASDAQ · Biotechnology

Solid Biosciences Inc

$9.08
+0.78 (+9.40%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +20.0% upside
Low Target $9.47
Average Target $10.90
High Target $14.24
Current Price $9.08
Current
$9.08
Target
$10.90
$9.47 $10.90 avg $14.24
Scenario Analysis
Bear Case
$9.47
4.3%
Low target
Base Case
$10.90
+20.0%
Avg target
Bull Case
$14.24
+56.8%
High target
Risk/Reward
13.2x
Highly favorable
Price in Context
52-Week High
$8.87
2.4% from high
52-Week Low
$3.79
+139.6% from low
Target vs 52W High
$10.90
+22.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%